NewsVenture Capital24/10/2022
Prime Medicine’s IPO: Moving Gene Editing Forward
GV →GV marked Prime Medicine’s IPO and described its earlier Series A co-leadership and continued investment. An IPO does not prove full disposal.
GV marked Prime Medicine’s IPO and described its earlier Series A co-leadership and continued investment. An IPO does not prove full disposal.